| Nancy Mcgreevy, APRN, BC | |
|
2868 Acton Rd, Birmingham, AL 35243-2502 | |
| (205) 968-8360 | |
| Not Available |
| Full Name | Nancy Mcgreevy |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Psychiatric/mental Health |
| Location | 2868 Acton Rd, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043482227 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WP0808X | Registered Nurse - Psychiatric/mental Health | 1-039674 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nancy Mcgreevy, APRN, BC 2868 Acton Rd, Birmingham, AL 35243-2502 Ph: (205) 968-8360 | Nancy Mcgreevy, APRN, BC 2868 Acton Rd, Birmingham, AL 35243-2502 Ph: (205) 968-8360 |
News Archive
Women with type 2 diabetes and cardiovascular disease (CVD), or at high risk of developing CVD, are less likely to reach recommended treatment targets than men, according to an international study involving almost 10,000 patients with type 2 diabetes, being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year (27 Sept-1 Oct). Nevertheless, women were less likely to experience adverse CVD outcomes apart from a stroke.
Wound Management Technologies, Inc. announced today that its CellerateRx product, distributed through its subsidiary Wound Care Innovations, LLC, will be highlighted in a presentation at the 23rd Annual Symposium on Advanced Wound Care and Wound Healing Society meeting April 17-20 in Orlando, Florida.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the Crohn's disease drug market, the dominance of TNF-alpha inhibitors such as Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade will continue over the next decade. Sales of Humira and Remicade, which accounted for more than three-quarters of the market in 2008, will continue to grow through 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Researchers have elucidated the disease risk underlying a biomarker predictive of shorter lifespan.
New recommendations co-developed by Dana-Farber Cancer Institute call for a significant expansion of the National Cancer Institute (NCI) and NCI-designated Comprehensive Cancer Centers to understand the causes of inequities in cancer care and a commitment to building sustained community partnerships to reduce them.
› Verified 5 days ago
Madison Thomas Hulker, WHNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1700 6th Ave S, Birmingham, AL 35233 Phone: 205-934-3411 | |
Shannon Marie Harrison, BSN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 619 19th St S, Birmingham, AL 35233 Phone: 205-934-6050 | |
Mrs. Leah York Richardson, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-242-8734 | |
Tyler Bishop, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1802 6th Ave S, Birmingham, AL 35233 Phone: 256-490-6381 | |
Emily Karanja, CRNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 50 Medical Park Dr E, Birmingham, AL 35235 Phone: 205-838-3245 | |
Emily Jane Bloom, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3419 Colonnade Pkwy Ste 600, Birmingham, AL 35243 Phone: 205-598-6800 Fax: 205-598-6700 | |
Latasha Davis, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 615 18th St S, Birmingham, AL 35233 Phone: 205-996-3050 |